De Fen Shen

851 total citations
36 papers, 659 citations indexed

About

De Fen Shen is a scholar working on Ophthalmology, Immunology and Neurology. According to data from OpenAlex, De Fen Shen has authored 36 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Ophthalmology, 14 papers in Immunology and 9 papers in Neurology. Recurrent topics in De Fen Shen's work include Ocular Diseases and Behçet’s Syndrome (11 papers), CNS Lymphoma Diagnosis and Treatment (9 papers) and Lymphoma Diagnosis and Treatment (8 papers). De Fen Shen is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (11 papers), CNS Lymphoma Diagnosis and Treatment (9 papers) and Lymphoma Diagnosis and Treatment (8 papers). De Fen Shen collaborates with scholars based in United States, France and Switzerland. De Fen Shen's co-authors include Chi‐Chao Chan, Nadine Tuaillon, Ronald Buggage, Phuc LeHoang, Zhengping Zhuang, Leaf Huang, Anthony H. C. Huang, Robert B. Nussenblatt, Bao Lu and Barrett J. Rollins and has published in prestigious journals such as Blood, Cancer Research and The FASEB Journal.

In The Last Decade

De Fen Shen

36 papers receiving 645 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
De Fen Shen United States 15 270 206 191 146 132 36 659
William A. Figgett Australia 11 39 0.1× 24 0.1× 78 0.4× 82 0.6× 135 1.0× 18 768
S. Yamamoto Japan 17 83 0.3× 18 0.1× 30 0.2× 92 0.6× 172 1.3× 38 766
Mônica Barbosa de Melo Brazil 16 342 1.3× 17 0.1× 27 0.1× 70 0.5× 362 2.7× 67 791
Selina McHarg United Kingdom 12 228 0.8× 8 0.0× 33 0.2× 27 0.2× 223 1.7× 18 605
Ikuro Maruyama Japan 10 8 0.0× 84 0.4× 47 0.2× 61 0.4× 99 0.8× 21 521
Lin Gao China 17 17 0.1× 18 0.1× 45 0.2× 116 0.8× 177 1.3× 41 669
Jodie Palmer Australia 13 7 0.0× 79 0.4× 51 0.3× 366 2.5× 259 2.0× 29 813
Satoru Komaki Japan 12 9 0.0× 55 0.3× 38 0.2× 49 0.3× 154 1.2× 35 394
A Goguel France 11 271 1.0× 6 0.0× 27 0.1× 29 0.2× 79 0.6× 27 867
Jonathan Digby‐Bell United Kingdom 5 43 0.2× 12 0.1× 18 0.1× 97 0.7× 331 2.5× 17 510

Countries citing papers authored by De Fen Shen

Since Specialization
Citations

This map shows the geographic impact of De Fen Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by De Fen Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites De Fen Shen more than expected).

Fields of papers citing papers by De Fen Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by De Fen Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by De Fen Shen. The network helps show where De Fen Shen may publish in the future.

Co-authorship network of co-authors of De Fen Shen

This figure shows the co-authorship network connecting the top 25 collaborators of De Fen Shen. A scholar is included among the top collaborators of De Fen Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with De Fen Shen. De Fen Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Cheng‐Rong, Kozaburo Hayashi, Yun Sang Lee, et al.. (2014). Suppressor of Cytokine Signaling 1 (SOCS1) Mitigates Anterior Uveitis and Confers Protection Against Ocular HSV-1 Infection. Inflammation. 38(2). 555–565. 11 indexed citations
2.
Chu, Xi, Yujuan Wang, De Fen Shen, et al.. (2013). Adult human RPE has greater susceptibility to IL17A-induced degeneration than fetal human RPE. Investigative Ophthalmology & Visual Science. 54(15). 1780–1780. 1 indexed citations
3.
Ardeljan, Daniel, Yujuan Wang, De Fen Shen, et al.. (2013). Interleukin-17 neutralization ameliorates retinal degeneration in Cx3cr1-/-/Ccl2-/-/Crb1rd8 mice. Investigative Ophthalmology & Visual Science. 54(15). 1713–1713. 2 indexed citations
5.
Shen, De Fen, Lai Wei, Yujuan Wang, et al.. (2012). IL-17A and IL-17RC Expression in the Macula of the Human Eye with Age-Related Macular Degeneration. Investigative Ophthalmology & Visual Science. 53(14). 1667–1667. 3 indexed citations
6.
Ardeljan, Daniel, Yujuan Wang, De Fen Shen, Jingsheng Tuo, & Chi‐Chao Chan. (2012). Treatment With Recombinant Interleukin-17A Reduces ARPE-19 Cell Viability. Investigative Ophthalmology & Visual Science. 53(14). 1227–1227. 2 indexed citations
7.
Ramkumar, Hema L., De Fen Shen, Jingsheng Tuo, et al.. (2012). IL-10 -1082 SNP and IL-10 in primary CNS and vitreoretinal lymphomas. Graefe s Archive for Clinical and Experimental Ophthalmology. 250(10). 1541–1548. 19 indexed citations
8.
Shen, De Fen, Jingsheng Tuo, Alexandra A. Herzlich, et al.. (2008). Chlamydia Pneumoniae Infection, Complement Factor H Variant, and Age-Related Macular Degeneration (AMD). Investigative Ophthalmology & Visual Science. 49(13). 1356–1356. 1 indexed citations
9.
Shen, De Fen, et al.. (2008). Chlamydia pneumoniae infection, complement factor H variants and age-related macular degeneration. British Journal of Ophthalmology. 93(3). 405–408. 17 indexed citations
10.
Li, Zhuqing, Sankaranarayana P. Mahesh, De Fen Shen, et al.. (2006). Eradication of Tumor Colonization and Invasion by a B Cell–Specific Immunotoxin in a Murine Model for Human Primary Intraocular Lymphoma. Cancer Research. 66(21). 10586–10593. 22 indexed citations
11.
Shen, De Fen, et al.. (2006). Hyporeactive Ocular Responses to Lipopolysaccharide in CCL2/CX3CR1 Double Deficient Mice. Investigative Ophthalmology & Visual Science. 47(13). 4521–4521. 1 indexed citations
12.
MacDonald, Ian M., et al.. (2005). REP–1 Localization in the Eye. Investigative Ophthalmology & Visual Science. 46(13). 540–540. 3 indexed citations
13.
Mansour, Ahmad M., M Crawford, De Fen Shen, et al.. (2005). Virus-induced chalazion. Eye. 20(2). 242–246. 11 indexed citations
14.
Cruz, Zenaida de la, et al.. (2005). CLINICOPATHOLOGIC AND ULTRASTRUCTURAL STUDY OF ENDOGENOUS KLEBSIELLA PNEUMONIAE ENDOPHTHALMITIS. Retina. 25(5). 657–662. 3 indexed citations
15.
Shen, De Fen, et al.. (2004). Endotoxin–Induced Uveitis is Diminished in Interferon–Gamma Receptor Deficient Mice. Investigative Ophthalmology & Visual Science. 45(13). 574–574. 2 indexed citations
16.
Tsilou, Ekaterini, Chi‐Chao Chan, Fabiano Sandrini, et al.. (2004). Eyelid myxoma in Carney complex without PRKAR1A allelic loss. American Journal of Medical Genetics Part A. 130A(4). 395–397. 23 indexed citations
17.
Akpek, Esen K., et al.. (2004). Lack of herpes virus DNA in choroidal tissues of a patient with serpiginous choroiditis☆. Ophthalmology. 111(11). 2071–2075. 4 indexed citations
18.
Buggage, Ronald, et al.. (2003). Effect of Sex Hormones on Experimental Autoimmune Uveoretinitis (EAU). Immunological Investigations. 32(4). 259–273. 23 indexed citations
19.
Shen, De Fen, Carl P. Herbort, Nadine Tuaillon, et al.. (2001). Detection of Toxoplasma Gondii DNA in Primary Intraocular B-Cell Lymphoma. Modern Pathology. 14(10). 995–999. 41 indexed citations
20.
Chan, Chi‐Chao, Ying Li, Bing Sun, et al.. (1998). Recombinant Adenovirus Encoding gp100 Modulates Experimental Melanin-Protein Induced Uveitis (EMIU). Journal of Autoimmunity. 11(2). 111–118. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026